MedEnvision pioneers new horizons with strategic Smile Invest partnership

March 1, 2024 – Westerlo, Belgium

MedEnvision, a leader in innovative orthopaedic efficiency solutions, is thrilled to announce a pivotal partnership with Smile Invest, a distinguished European investment firm known for its focus on fostering innovative growth companies. This strategic partnership aims to fuel MedEnvision’s international expansion, drive new product development, and unlock new market opportunities.

Founded on the principles of enhancing efficiency in orthopaedic surgeries, MedEnvision has revolutionized the operating theatre with its patented product range, including the Gripper set, the EsySuit range, and specially designed retractors. These innovations offer dual benefits: they optimize time and resources by freeing OR staff for more critical tasks while providing surgeons with enhanced control in surgeries involving the hip, knee, and shoulder. Currently, MedEnvision’s solutions have reached 26 countries, with a strong presence in the Benelux and the US.

Dries Goyens, CEO of MedEnvision, expressed enthusiasm about the new partnership: “We are honoured to welcome Smile Invest into our company. Their proven track record in nurturing high-potential healthcare innovations aligns with our vision. This collaboration not only validates the impact of our products but also equips us with the strategic and financial support necessary to broaden our global footprint and continue improving surgical workflows.”

Bart Cauberghe, Managing Partner at Smile Invest, shared his perspective on the collaboration: “MedEnvision represents the type of innovation and strategic foresight we value at Smile Invest. Their solutions directly address some of the most pressing challenges in healthcare today, such as improving procedural efficiency and mitigating the impact of nursing staff shortages. We are confident in MedEnvision’s growth trajectory and its role in advancing orthopaedic care for an ageing population aspiring to maintain an active lifestyle.”

This strategic partnership between MedEnvision and Smile Invest has been established with the support of the financial advisory firm Merodis.

About Smile Invest

Smile Invest (Smart Money for Innovation Leaders) is an evergreen investment firm with a portfolio exceeding €500 million in assets under management. Supported by 40 entrepreneurial families, Smile Invest focuses on digitalization, healthcare, and sustainability. Established in 2017, Smile Invest has since curated a diverse portfolio of 15 companies across Europe. Operating from Leuven and The Hague, Smile Invest is dedicated to empowering ambitious entrepreneurs and their teams to realize their growth ambitions. For more information, please visit:

About MedEnvision

MedEnvision, a rapidly growing medtech company, specializes in developing innovative solutions to enhance efficiency, ergonomics, and infection control in the operating room (OR). Their flagship products, including the Gripper™, EsySuit™, and Esy Solution™, are designed to streamline OR processes, enabling surgeons and their teams to operate more effectively and focus on patient care. With a strong commitment to improving hospital workflows and outcomes, MedEnvision stands as a partner in optimizing surgical procedures worldwide. For more information, please visit

About Merodis

Merodis provides middle-market companies and, or their shareholders with an ultra-focused, highly qualitative financial advisory service in support of trade sales (divestitures) or acquisitions and financing. For more information, recent transactions and credentials, please visit

Contact Information:

To learn more about MedEnvision and its innovative solutions, please contact

This partnership with Smile Invest marks a new chapter in MedEnvision’s journey towards enhancing orthopaedic healthcare delivery through innovative surgical workflow solutions.

Compartilhe esta postagem